Table 2.
Population | 5-Year prevalent case | 5-Year prevalencea | New case | Crude incidencea | Age-standardized incidencea | Death | Crude mortalitya | Age-standardized mortalitya |
---|---|---|---|---|---|---|---|---|
China | 1,248,644 | 87.7c | 521,490 | 36.6c | 23.7c | 247,563 | 17.4c | 10.9c |
Japan | 431,679 | 339.4d | 148,151 | 116.5d | 38.9d | 57,910 | 45.5d | 12.0c |
Korea | 122,933 | 240.3d | 42,363 | 82.8d | 44.5d | 9,762 | 19.1c | 8.7c |
India | 113,046 | 8.3b | 56,751 | 4.2b | 4.4b | 43,090 | 3.2b | 3.4b |
Indonesia | 66,175 | 24.8b | 30,017 | 11.3b | 12.1b | 16,386 | 6.1b | 6.9b |
Turkey | 49,614 | 60.6c | 20,031 | 24.5c | 21.0c | 10,033 | 12.2c | 10.2c |
Thailand | 42,417 | 61.3c | 17,534 | 25.3c | 15.5b | 9,462 | 13.7c | 8.4c |
Philippines | 34,268 | 32.2b | 15,680 | 14.7b | 18.9c | 8,821 | 8.3b | 11.0c |
Vietnam | 32,895 | 34.1b | 14,733 | 15.3b | 13.4b | 8,104 | 8.4b | 7.0b |
Iran | 24,345 | 29.7b | 9,864 | 12.0b | 12.9b | 4,153 | 5.1b | 5.6b |
Asia | 2,356,976 | 51.9 | 957,896 | 21.1 | 17.7 | 461,422 | 10.2 | 8.3 |
Proportions per 100,000.
Rate < world proportion.
Rate ≥ world proportion & <2×world proportion.
Rate ≥ 2×world proportion.
Data source: International Agency for Research on Cancer, GLOBOCAN 2018, World Health Organization (WHO) [4].